About Us
The International Journal of Molecular Oncology (IJMO) is a peer-reviewed, open-access scholarly journal dedicated to publishing high-quality research that advances the molecular understanding of cancer and its clinical translation.
IJMO aims to bridge basic molecular discoveries with innovative diagnostic, prognostic, and therapeutic strategies, fostering progress in precision oncology and personalized cancer medicine.
Scholars around the world come together to publish IJMO, a journal that is scrutinized prior to publication. Go to the IJMO site to get the information first hand.
The peer-reviewed, national, open-access Journal of Molecular Oncology publishes original articles and reviews on all aspects of cancer biology, molecular medicine, and related research in the field of oncology.
IJMO has aspirations of participating in the science-clinic dialogue by encouraging studies that enhance diagnostics, treatment, and patient outcomes.
Our Focus
We welcome research involving biological, genetic, and biochemical foundations of cancer and cancer-related ailments.
Article Categories
- Original Research Articles
- Review Articles
- Short Communications
- Case Report and Clinical Study
- Translational and Experimental Research
Key Areas of Interest
- Oncology at Molecular and Cellular Level
- Cancer Genetics and Genomics
- Tumor Biology and Pathology
- Immuno-Oncology
- Cancer Therapy and Drug Design
- Biomarkers and Diagnostic Technologies
- Clinical and Translational Oncology
- Precision and Personalized Medicine
- Cancer Epidemiology and Prevention
Open Access for Global Reach
All IJMO articles are freely accessible online, enabling immediate sharing and global dissemination of scientific knowledge without barriers.
Quality and Peer Review
Every submission undergoes a rigorous peer-review process to ensure scientific integrity, transparency, and reliability.
A Society of Scientific Advances
IJMO is a growing academic community fostering innovation, collaboration, and discovery in oncology research and patient care.
